1,303 Shares in Semler Scientific, Inc. (NASDAQ:SMLR) Bought by AJOVista LLC

AJOVista LLC purchased a new stake in Semler Scientific, Inc. (NASDAQ:SMLR) in the 4th quarter, HoldingsChannel reports. The fund purchased 1,303 shares of the company’s stock, valued at approximately $58,000.

Other hedge funds have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC boosted its stake in Semler Scientific by 128.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 58,560 shares of the company’s stock valued at $2,594,000 after acquiring an additional 32,921 shares during the last quarter. LSV Asset Management raised its holdings in Semler Scientific by 27.5% during the 3rd quarter. LSV Asset Management now owns 144,546 shares of the company’s stock valued at $3,667,000 after acquiring an additional 31,215 shares during the period. Trexquant Investment LP purchased a new position in Semler Scientific during the 3rd quarter valued at about $345,000. Exchange Traded Concepts LLC bought a new stake in shares of Semler Scientific during the fourth quarter valued at about $383,000. Finally, Summit Global Investments purchased a new stake in shares of Semler Scientific in the fourth quarter worth about $346,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Performance

Shares of SMLR stock opened at $27.25 on Monday. The company has a market capitalization of $191.57 million, a PE ratio of 10.23 and a beta of 0.92. Semler Scientific, Inc. has a 52-week low of $22.82 and a 52-week high of $53.38. The business’s fifty day moving average is $31.02 and its 200 day moving average is $37.69.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Tuesday, March 5th. The company reported $0.55 earnings per share for the quarter. The company had revenue of $15.06 million for the quarter. Semler Scientific had a net margin of 30.19% and a return on equity of 30.60%.

Analyst Ratings Changes

Separately, TheStreet raised shares of Semler Scientific from a “c+” rating to a “b-” rating in a research note on Friday, March 1st.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.